Search

21 results for “type 1 diabetes”

• Research PaperOpen Access

  Is the peripheral arterial disease in low risk type 2 diabetic patients influenced by body mass index, lipidemic control, and statins?

  Jayesh Dalpatbhai Solanki, Amit H. Makwana, Hemant B. Mehta, Pradnya A. Gokhale, Chinmay J. Shah

  Vol. 7 · Issue 2 · pp. 87–92

  https://doi.org/10.4103/0976-500X.184772
  Full text ↗PDF

• Research ArticleOpen Access

  Use of Fixed-dose Combination Therapy with Remogliflozin and Vildagliptin as an Add-on Drug in Improving the Glycemic Control of Type 2 Diabetes Mellitus: An Observational Study

  Velammal Petchiappan, Elsa Mathew, Josna Jose, Mohamed Fardan, Yoganathan Chidambaram, Saravanan Thangavelu

  Vol. 14 · Issue 1 · pp. 72–78

  https://doi.org/10.1177/0976500X231175219
  Full text ↗PDF

• Educational ForumOpen Access

  Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus

  Darshan J. Dave

  Vol. 2 · Issue 4 · pp. 230–235

  https://doi.org/10.4103/0976-500X.85934
  Full text ↗PDF

• Research PaperOpen Access

  Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients

  Suyog Sindhu, Hemant Kumar Singh, Mohammad Tariq Salman, Jalees Fatima, Vinod Kumar Verma

  Vol. 2 · Issue 4 · pp. 261–265

  https://doi.org/10.4103/0976-500X.85954
  Full text ↗PDF

• Research LetterOpen Access

  Prescribing pattern of drugs for cardiovascular co-morbidities in type 2 diabetes mellitus in a tertiary care Indian hospital

  Dakshinamurthy Nishanthini, Balan Aravinda Kumar, Chandrashekaran Girish, Sadasivam Balakrishnan

  Vol. 5 · Issue 1 · pp. 54–55

  https://doi.org/10.4103/0976-500X.124424
  Full text ↗PDF

• Research PaperOpen Access

  Protective role of glibenclamide against nicotinamide-streptozotocin induced nuclear damage in diabetic Wistar rats

  Syed Imam Rabbani, Kshama Devi, Salma Khanam

  Vol. 1 · Issue 1 · pp. 18–23

  https://doi.org/10.4103/0976-500X.64531
  Full text ↗PDF

• Review ArticleOpen Access

  Treatment Considerations and Pharmacist Collaborative Care in Diabetic Ketoacidosis Management

  Alanood Algarni

  Vol. 13 · Issue 3 · pp. 215–221

  https://doi.org/10.1177/0976500X221128643
  Full text ↗PDF

• Research PaperOpen Access

  Secondary metabolites of Cynodon dactylon as an

  antagonist to angiotensin II type1 receptor: Novel in

  Vol. 3 · Issue 1 · pp. 20–25

  https://doi.org/10.4103/0976-500X.92497
  Full text ↗PDF

• Review ArticleOpen Access

  Adipocytokines: The pied pipers

  Hardik Gandhi, Aman Upaganlawar, Balaraman R

  Vol. 1 · Issue 1 · pp. 9–10

  https://doi.org/10.4103/0976-500X.64530
  Full text ↗PDF

• Mini ReviewOpen Access

  Iptakalim: A novel multi-utility potassium channel opener

  (Kir6.1s) (Kir6.1s), regulatory sulphonylurea subunits (SUR).[3] IPT shows high selectivity for cardiac KATP (SUR2A/Kir6.2), vascular KATP (SUR2B/Kir6.1 or SUR6B/Kir6.2). Because

  Vol. 3 · Issue 1 · pp. 12–14

  https://doi.org/10.4103/0976-500X.92495
  Full text ↗PDF

• Case ReportOpen Access

  Insulin glargine overdose

  Fatma Sarı Doğan, Özge Ecmel Onur, Arzu Denizbaşı Altınok, Özlem Güneysel

  Vol. 3 · Issue 4 · pp. 333–335

  https://doi.org/10.4103/0976-500X.103694
  Full text ↗PDF

• Research LetterOpen Access

  Methylcobalamin in Vitamin B12 Deficiency: To Give or not to Give?

  Ashwin Kamath, Sudhakar Pemminati

  Vol. 8 · Issue 1 · pp. 33–34

  https://doi.org/10.4103/jpp.JPP_173_16
  Full text ↗PDF

• Research ArticleOpen Access

  Pharmacodynamic Interaction of Areca catechu with Gliclazide in Wistar Rats

  Suliman Abdullah Al-Omran, Dharmashree S, Anil Kumar KV, Sreeharsha Nagaraja

  Vol. 15 · Issue 1 · pp. 69–77

  https://doi.org/10.1177/0976500X241231365
  Full text ↗PDF

• Research LetterOpen Access

  Modulation of inflammatory pain in response to a CCR2/CCR5 antagonist in rodent model

  Masayuki Okamoto, Takeshi Suzuki, Nobuhide Watanabe

  Vol. 4 · Issue 3 · pp. 208–210

  https://doi.org/10.4103/0976-500X.114605
  Full text ↗PDF

• CommentaryOpen Access

  The metabolic syndrome and schizophrenia: A comorbidity or an association?

  Vol. 4 · Issue 3 · pp. 174–175

  Full text ↗PDF

• Original PaperOpen Access

  Pharmacokinetic and pharmacodynamic drug interactions of carbamazepine and glibenclamide in healthy albino Wistar rats

  S. Prashanth, A. Anil Kumar, B. Madhu, N. Rama, J. Vidya Sagar

  Vol. 2 · Issue 1 · pp. 7–8

  https://doi.org/10.4103/0976-500X.77083
  Full text ↗PDF

• Research ArticleOpen Access

  Competitive Analysis of the Binding Affinity of Montelukast, Zafirlukast and Gemilukast to CysLTR1, P2Y12 and PPAR-γ and their Possible Cardioprotective Effect: Using in silico Methods

  Matrika Saha Roy, Bidduth Kumar Sarkar, Md Rohan Nadvi, Arghya Prosun Sarkar, Sukalyan Kumar Kundu, Hossain Ahmed, Md Jahirul Islam, Barno Kumar Sarkar, Peter Singh, Tanushree Maitra, Maruf Hasan

  Vol. 15 · Issue 1 · pp. 28–37

  https://doi.org/10.1177/0976500X241232235
  Full text ↗PDF

• Letter to the EditorOpen Access

  The Science of Antioxidants: Balancing the Pros and Cons for Our Health

  Mueen Ahmed K. K.

  Vol. 14 · Issue 2 · pp. 160–162

  https://doi.org/10.1177/0976500X231182792
  Full text ↗PDF

• Case ReportOpen Access

  Bullous Drug Reaction with Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

  K. Geetha, Puja Puja

  Vol. 13 · Issue 1 · pp. 99–101

  https://doi.org/10.1177/0976500X221080309
  Full text ↗PDF

• Case ReportOpen Access

  Hypokalemia and rhabdomyolysis

  Henrik Horwitz, Vidar A. Woeien, Linda Wiuff Petersen, Espen Jimenez‑Solem

  Vol. 6 · Issue 2 · pp. 98–99

  https://doi.org/10.4103/0976-500X.155488
  Full text ↗PDF